Docket
36848
Britton Low v. Pfizer Canada Inc., et al.
(British Columbia) (Civil) (By Leave)
Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.
Date | Proceeding | Filed By (if applicable) |
---|---|---|
2016-06-14 | Close file on Leave | |
2016-06-10 | Copy of formal judgment sent to Registrar of the Court of Appeal and all parties | |
2016-06-10 | Judgment on leave sent to the parties | |
2016-06-09 | Judgment of the Court on the application for leave to appeal, The motion for an extension of time to serve and file the motion for leave to intervene is dismissed. The application for leave to appeal from the judgment of the Court of Appeal for British Columbia (Vancouver), Number CA42139, 2015 BCCA 506, dated December 8, 2015, is dismissed with costs. Dismissed, with costs |
|
2016-06-09 | Decision on motion to extend time, see judgment on leave application Dismissed |
|
2016-05-09 | All materials on application for leave submitted to the Judges, Abe Ka Br | |
2016-05-09 | Submission of motion to extend time, Abe Ka Br | |
2016-05-09 | Submission of motion for leave to intervene, Abe Ka Br | |
2016-04-25 | Reply to the motion for leave to intervene., (Letter Form), Completed on: 2016-04-25, (Electronic version filed on 2016-04-27) | Canadian Generic Pharmaceutical Association |
2016-04-18 | Response to the motion for leave to intervene, (Letter Form), Completed on: 2016-04-18, (Electronic version filed on 2016-04-18) | Pfizer Canada Inc. |
2016-04-18 | Response to the motion for leave to intervene, (Letter Form), Completed on: 2016-04-18, (Electronic version filed on 2016-04-18) | Britton Low |
2016-04-15 | Book of authorities, (Book Form), (2 volumes), (Electronic version filed on 2016-04-15) | Canadian Generic Pharmaceutical Association |
2016-04-07 | Motion to extend time, (Book Form), (Included in the motion for leave to intervene), Completed on: 2016-04-07, (Electronic version filed on 2016-04-08) | Canadian Generic Pharmaceutical Association |
2016-04-07 | Motion for leave to intervene, (Book Form), only submit 2 copies. 4 copies missing. All the copies received 2016-04-08., Completed on: 2016-04-07, (Electronic version filed on 2016-04-08) | Canadian Generic Pharmaceutical Association |
2016-03-21 | Applicant's reply to respondent's argument, (Book Form), Completed on: 2016-03-21, (Electronic version filed on 2016-03-21) | Britton Low |
2016-03-11 | Book of authorities, (Book Form) | Pfizer Canada Inc. |
2016-03-11 | Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2016-03-14) | Pfizer Canada Inc. |
2016-03-11 | Notice of name, (Letter Form), Pfizer Research and Development Company N.V./S.A., (Electronic version filed on 2016-03-14) | Pfizer Canada Inc. |
2016-03-11 | Notice of name, (Letter Form), Pfizer Ireland Pharmaceuticals, (Electronic version filed on 2016-03-14) | Pfizer Canada Inc. |
2016-03-11 | Notice of name, (Letter Form), Pfizer Inc., (Electronic version filed on 2016-03-14) | Pfizer Canada Inc. |
2016-03-11 | Notice of name, (Letter Form), Pfizer Canada Inc., (Electronic version filed on 2016-03-14) | Pfizer Canada Inc. |
2016-03-11 | Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2016-03-11, (Electronic version filed on 2016-03-14) | Pfizer Canada Inc. |
2016-02-18 | Correspondence received from, (Letter Form), Estimated time to file the Final CA Order 2016-04-20. | Britton Low |
2016-02-11 | Letter acknowledging receipt of an incomplete application for leave to appeal and without formal Court of Appeal order, file opened 2016-02-11. | |
2016-02-08 | Book of authorities, (Book Form), (3 volumes) | Britton Low |
2016-02-08 | Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2016-02-16) | Britton Low |
2016-02-08 | Application for leave to appeal, (Book Form), CA Order missing. Expected 2016-04-20. Received 2016-03-14., Completed on: 2016-03-15, (Electronic version filed on 2016-02-16) | Britton Low |
- Date modified: